-
iPSC TechnologyContact Information
- Address: 8F, 55 Magokdong-ro, Gangseo-gu, Seoul, Republic of Korea(07802)
- Business Registration No.: 109-86-37282
- CEO: Choongseong Han
- Tel: +82-2-2088-8886
- Fax: +82-2-2088-8884
- E-mail: support@nexel.co.kr
-
News
- Home
- News
- News
News
Total 20
Celogics Licenses in NEXEL's Cardiosight-S for Global Distribution
Nexel, 'Chinese Patent Registration' for New Drug Candidate for NASH Fibrosis
Curi Bio and NEXEL Announce Celogics, Joint Venture to Develop Leading iPSC-derived Cell Products
NEXEL Co., Ltd. signed Strategic Business Partnership Agreement with Next&Bio
Korea Ministry of Food and Drug Safety Issues a Revised Guideline on Cardiac Safety Pharmacology
NEXEL Co., Ltd. raises USD 15.6 million in bridge round
NEXEL Co., Ltd. signs Memorandum of Understanding with KangWon National University School of Medicine
NEXEL, "US Patent Registration" for New Drug Candidate for Liver Fibrosis
NEXEL and Nanion Technologies partner to open a new reference demonstration laboratory
Covid-19 Update